Hepatitis C
Showing NaN - NaN of 53
Hepatitis C, HIV, Opioid-use Disorder Trial in Boston (PRC brief motivational interview intervention, Phone contact)
Completed
- Hepatitis C
- +2 more
- PRC brief motivational interview intervention
- Phone contact
-
Boston, MassachusettsBoston Medical Center - Low-Barrier-Access (LBA) walk-in clinic
Nov 18, 2022
HCV-TARGET- Hepatitis C Therapeutic Registry and Research
Active, not recruiting
- Hepatitis C
-
Phoenix, Arizona
- +59 more
Oct 5, 2022
Hepatitis C, Awaiting Organ Transplant Trial in Boston (Sofosbuvir/velpatasvir, Monitoring)
Recruiting
- Hepatitis C
- Awaiting Organ Transplant
- Sofosbuvir/velpatasvir
- Monitoring
-
Boston, MassachusettsBrigham and Women's Hospital
Mar 14, 2022
Renal Failure Chronic, Hepatitis C Trial in United States (glecaprevir/pibrentasvir treatment)
Completed
- Renal Failure Chronic
- Hepatitis C
- glecaprevir/pibrentasvir treatment
-
Chicago, Illinois
- +6 more
Jan 18, 2022
Hepatitis C Trial in Worldwide (SOF/VEL for 6 weeks, SOF/VEL for 12 weeks)
Completed
- Hepatitis C
- SOF/VEL for 6 weeks
- SOF/VEL for 12 weeks
-
Baltimore, Maryland
- +24 more
Nov 22, 2021
HIV, Hepatitis C Trial in Puerto Rico, United States (Pegylated-Interferon Alfa 2b (PEG-IFN), Ribavirin (RBV), Boceprevir (BOC))
Completed
- HIV Infections
- Hepatitis C
- Pegylated-Interferon Alfa 2b (PEG-IFN)
- +2 more
-
Birmingham, Alabama
- +42 more
Nov 2, 2021
An Observational Study of Hepatitis C Virus in Pregnancy
Completed
- Hepatitis C
-
Birmingham, Alabama
- +16 more
Sep 21, 2021
Direct Acting Antiviral-Post Authorization Safety Study
Completed
- Hepatitis C
- Hepatocellular Carcinoma
-
Phoenix, Arizona
- +61 more
Jul 1, 2021
Kidney Failure, Hepatitis C, Kidney Disease, Chronic Trial in Boston (Glecaprevir and Pibrentasvir)
Recruiting
- Kidney Failure
- +2 more
- Glecaprevir and Pibrentasvir
-
Boston, MassachusettsMassachusetts General Hospital
Jun 4, 2021
HIV, Hepatitis C Trial in Boston (Questionnaire, Rapid finger stick, Venipuncture)
Completed
- HIV
- Hepatitis C
- Questionnaire
- +2 more
-
Boston, MassachusettsBoston Medical Center
Dec 10, 2020
Hepatitis C, HIV, AIDS Trial in United States (Control Group, Care Facilitation Group)
Completed
- Hepatitis C
- +3 more
- Control Group
- Care Facilitation Group
-
Birmingham, Alabama
- +10 more
Jul 21, 2020
Hepatitis C, HCV Trial in United States (Glecaprevir/Pibrentasvir (G/P) 300mg/120mg, Ribavirin 200Mg Tablet)
Completed
- Hepatitis C
- HCV
- Glecaprevir/Pibrentasvir (G/P) 300mg/120mg
- Ribavirin 200Mg Tablet
-
Palo Alto, California
- +30 more
Feb 17, 2020
Hepatitis C Trial in Boston (Sofosbuvir/Velpatasvir Treatment for 14 days)
Withdrawn
- Hepatitis C
- Sofosbuvir/Velpatasvir Treatment for 14 days
-
Boston, MassachusettsMassachusetts General Hospital
Jan 16, 2020
Hepatitis C, Chronic Kidney Disease Trial in Boston (Sofosbuvir/Ledipasvir FDC)
Terminated
- Hepatitis C
- Chronic Kidney Disease
- Sofosbuvir/Ledipasvir FDC
-
Boston, MassachusettsMassachusetts General Hospital
Jan 8, 2020
Kidney Failure, Kidney Diseases, Hepatitis C Trial in Boston (glecaprevir/pibrentasvir tablets)
Withdrawn
- Kidney Failure
- +2 more
- glecaprevir/pibrentasvir tablets
-
Boston, MassachusettsMassachusetts General Hospital
May 30, 2019
C Tracker, Hepatitis C, Care & Collaboration - Patient Reported
Terminated
- Hepatitis C
-
Boston, MassachusettsChildren's Hospital Boston
Jan 30, 2019
Cardiac Transplant Disorder, Hepatitis C Trial in Boston (Combindation treatment with Grazoprevir and Elbasvir fixed dose
Withdrawn
- Cardiac Transplant Disorder
- Hepatitis C
- Combindation treatment with Grazoprevir and Elbasvir fixed dose combination tablet, with or without ribavirin
-
Boston, MassachusettsMasschusetts General Hospital
Dec 18, 2018
Renal Failure Chronic, Hepatitis C Trial in Boston (Zepatier, Zepatier plus Sofosbuvir)
Withdrawn
- Renal Failure Chronic
- Hepatitis C
- Zepatier
- Zepatier plus Sofosbuvir
-
Boston, MassachusettsMassachusetts General Hospital
Dec 18, 2018